Loading...

We deliver the promise of better therapies

2016
  • Seed of the idea sown
    • Dr. Nusrat Sanghamitra’s breakthrough journey began with the BIG Grant, which offered the vital seed support to establish her proof of concept.
2017-20
  • First In-vitro proof of concept
  • Worldwide recognition of technology
    • DST-CII-AICTE i3 Gold Award for Top Innovator
    • DST-Lockheed Martin India Innovation Growth Program IIGP 2.0
    • National award for Technology Startup with Commercialization Potential by Honorable President of India
    • Cancer Innovation Challenge Award
    • Most Innovative Product Award, Enterprise Ireland
    • She Loves Tech Global Startup Competition
    • TiE-BIRAC WinER (Women in Entrepreneurial Research) Award
    • Leaders in Innovation Fellowship (by the Royal Academy of Engineering)
  • Competitive grants secured
    • Competitive Awards and Recognitions: ~USD 70,000
    • Innovation Voucher and New Frontiers Scholarship: USD 28,000
    • BPCL Ankur Startup Grant: USD 1,63,000
  • Three CLNs (USD 2,95,000) from SOSV, Ireland
2021-22
  • In-vivo proof of concept in mice
  • Seed round closed (USD 14,00,000)
  • First patent granted (US)
2023-24
  • Research partnerships and industry collaborations established
  • Three additional patents granted (US, Japan, EU)
  • USFDA Orphan Drug Designation secured
2025-
  • In-vivo proof of concept for RNA delivery in mice
  • Bridge round closed (USD 16,00,000)
  • .
  • .
  • .
  • .
  • and still growing!
2016
  • Seed of the idea sown
    • Dr. Nusrat Sanghamitra’s breakthrough journey began with the BIG Grant, which offered the vital seed support to establish her proof of concept.
2017-20
  • First In-vitro proof of concept
  • Worldwide recognition of technology
    • DST-CII-AICTE i3 Gold Award for Top Innovator
    • DST-Lockheed Martin India Innovation Growth Program IIGP 2.0
    • National award for Technology Startup with Commercialization Potential by Honorable President of India
    • Cancer Innovation Challenge Award
    • Most Innovative Product Award, Enterprise Ireland
    • She Loves Tech Global Startup Competition
    • TiE-BIRAC WinER (Women in Entrepreneurial Research) Award
    • Leaders in Innovation Fellowship (by the Royal Academy of Engineering)
  • Competitive grants secured
    • Competitive Awards and Recognitions: ~USD 70,000
    • Innovation Voucher and New Frontiers Scholarship: USD 28,000
    • BPCL Ankur Startup Grant: USD 1,63,000
  • Three CLNs (USD 2,95,000) from SOSV, Ireland
2021-22
  • In-vivo proof of concept in mice
  • Seed round closed (USD 14,00,000)
  • First patent granted (US)
2023-24
  • Research partnerships and industry collaborations established
  • Three additional patents granted (US, Japan, EU)
  • USFDA Orphan Drug Designation secured
2025-
  • In-vivo proof of concept for RNA delivery in mice
  • Bridge round closed (USD 16,00,000)
  • .
  • .
  • .
  • .
  • and still growing!

Our Mission

To revolutionize intracellular drug delivery through our innovative GEENIE platform, enhancing therapeutic efficacy and safety across a broad spectrum of diseases. We are committed to transforming intracellular therapeutics by enabling more effective treatments with reduced side effects.

Our Vision

To become the global leader in targeted intracellular delivery, establishing GEENIE as the gold standard for delivering therapeutic molecules safely and efficiently, transforming treatments for oncology and rare genetic diseases.

Our Executive Leadership


Dr. Nusrat Sanghamitra

Founder & CEO



Dr. Fazlul Haque Krishnan

Co-founder & Director



Our Board and Advisors


Bill Liao

Board Chair



Dr. Nusrat Sanghamitra

Founder, CEO & Board Member



Imran Nasrullah

Board Member & Advisor (Pharma Deals)



David Rowan

Board Member



Dr. Satya Prakash Dash

Board Member



Sami Mikati

Board Observer



Ravikrishna Cherukuri

Board Observer



Erin Mistry

Advisor (Commercialization)



Michael S Wyand

Advisor (Clinical Development)



Dr. Eoin Fleming

Advisor (Protein Engineering)



JB Michel

Advisor (Product Development)



Join Our Team

Our diverse team of scientists, researchers, and business professionals is united by a shared mission: to transform therapeutic delivery and improve patient outcomes worldwide.

Careers@CyGenica

We’re always looking for talented individuals who share our passion for innovation and commitment to scientific excellence. Whether you're a specialist in protein engineering, cell biology, business development, or operations, we welcome your expertise.

What makes CyGenica so exciting is that its ground-breaking technology can amplify the positive impact of therapies being developed by some of the world’s leading biopharmaceutical companies. Your work with us has the potential to reach far beyond CyGenica and help transform the treatment of a wide range of cancers and rare genetic diseases.

You'll be part of an international team committed to combining our individual talents for the greater good, acting with honesty and integrity, and pursuing great science, driven by a shared desire to be agents of positive change.

If this sounds like you, we’d love to hear from you. Contact us at info@cygenica.com.

Chief Executive Officer and Chairman of the Board